Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Feb 11 1998
WASHINGTON, D.C. (February 11, 1998) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement after...
Jan 7 1998
(WASHINGTON, D.C., January 7, 1998)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement in...
Nov 21 1997
WASHINGTON, D.C. (November 21, 1997) _ Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement...
Nov 10 1997
(WASHINGTON, DC, November 10, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement in...
Nov 7 1997
(WASHINGTON, DC, October 7, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the House...
Jul 24 1997
(WASHINGTON, DC)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement in response to the...
Jul 22 1997
(WASHINGTON, DC)...The Biotechnology Industry Organization (BIO) has been honored by the Public Relations Society of America (PRSA)/Richmond, VA chapter, for...
Jun 19 1997
WASHINGTON, D.C., --- Gordon Binder, Chairman and CEO of Amgen Inc. has been elected Chairman of the Board for the Biotechnology Industry Organization (BIO...
Jun 7 1997
WASHINGTON, D.C.----Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today in response to the...


Biotechnology News

August 30, 2014

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of a pre-specified secondary...

August 29, 2014

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare (NYSE: IVC) announces sale of Altimate Medical to Rockwood Equity Partners for approximately $23,000,000 in cash, subject to an...

August 29, 2014

BOSTON--(BUSINESS WIRE)--Boston Strategics has begun a Phase 1 clinical trial of FUJIFILM’s anti-cancer agent FF-10501 in patients with advanced hematologic malignancies...

August 29, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, announced today that it is initiating a nationwide recall of certain lots...

August 29, 2014

SARASOTA, Fla.--(BUSINESS WIRE)--BioFlorida's Sarasota-Bradenton Chapter debuts the first BioTech Expo in the region to include a combination Life Science Poster &...